Literature DB >> 22853955

Coxsackievirus B3 mutator strains are attenuated in vivo.

Nina F Gnädig1, Stéphanie Beaucourt, Grace Campagnola, Antonio V Bordería, Marta Sanz-Ramos, Peng Gong, Hervé Blanc, Olve B Peersen, Marco Vignuzzi.   

Abstract

Based on structural data of the RNA-dependent RNA polymerase, rational targeting of key residues, and screens for Coxsackievirus B3 fidelity variants, we isolated nine polymerase variants with mutator phenotypes, which allowed us to probe the effects of lowering fidelity on virus replication, mutability, and in vivo fitness. These mutator strains generate higher mutation frequencies than WT virus and are more sensitive to mutagenic treatments, and their purified polymerases present lower-fidelity profiles in an in vitro incorporation assay. Whereas these strains replicate with WT-like kinetics in tissue culture, in vivo infections reveal a strong correlation between mutation frequency and fitness. Variants with the highest mutation frequencies are less fit in vivo and fail to productively infect important target organs, such as the heart or pancreas. Furthermore, whereas WT virus is readily detectable in target organs 30 d after infection, some variants fail to successfully establish persistent infections. Our results show that, although mutator strains are sufficiently fit when grown in large population size, their fitness is greatly impacted when subjected to severe bottlenecking, which would occur during in vivo infection. The data indicate that, although RNA viruses have extreme mutation frequencies to maximize adaptability, nature has fine-tuned replication fidelity. Our work forges ground in showing that the mutability of RNA viruses does have an upper limit, where larger than natural genetic diversity is deleterious to virus survival.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22853955      PMCID: PMC3427060          DOI: 10.1073/pnas.1204022109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease.

Authors:  K Nundita Reetoo; Shabina A Osman; Shirin J Illavia; Charlotte L Cameron-Wilson; Jangu E Banatvala; Peter Muir
Journal:  J Gen Virol       Date:  2000-11       Impact factor: 3.891

2.  Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).

Authors:  Carmen M Ruiz-Jarabo; Calvin Ly; Esteban Domingo; Juan Carlos de la Torre
Journal:  Virology       Date:  2003-03-30       Impact factor: 3.616

Review 3.  Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin.

Authors:  Shane Crotty; Raul Andino
Journal:  Microbes Infect       Date:  2002-11       Impact factor: 2.700

4.  Nucleotide sequence heterogeneity of an RNA phage population.

Authors:  E Domingo; D Sabo; T Taniguchi; C Weissmann
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

5.  RNA virus error catastrophe: direct molecular test by using ribavirin.

Authors:  S Crotty; C E Cameron; R Andino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

6.  Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution.

Authors:  P E Tam; R P Messner
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis.

Authors:  Jason D Graci; Nina F Gnädig; Jessica E Galarraga; Christian Castro; Marco Vignuzzi; Craig E Cameron
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

8.  A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity.

Authors:  Julie K Pfeiffer; Karla Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

9.  Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus.

Authors:  Nonia Pariente; Antero Airaksinen; Esteban Domingo
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase.

Authors:  Aaron A Thompson; Olve B Peersen
Journal:  EMBO J       Date:  2004-08-12       Impact factor: 11.598

View more
  79 in total

1.  Dynamic viral dissemination in mice infected with yellow fever virus strain 17D.

Authors:  Andrea K Erickson; Julie K Pfeiffer
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Rational Control of Poliovirus RNA-Dependent RNA Polymerase Fidelity by Modulating Motif-D Loop Conformational Dynamics.

Authors:  Jingjing Shi; Jacob M Perryman; Xiaorong Yang; Xinran Liu; Derek M Musser; Alyson K Boehr; Ibrahim M Moustafa; Jamie J Arnold; Craig E Cameron; David D Boehr
Journal:  Biochemistry       Date:  2019-08-26       Impact factor: 3.162

3.  Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens.

Authors:  Nicole R Sexton; Everett Clinton Smith; Hervé Blanc; Marco Vignuzzi; Olve B Peersen; Mark R Denison
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

4.  Structural dynamics as a contributor to error-prone replication by an RNA-dependent RNA polymerase.

Authors:  Ibrahim M Moustafa; Victoria K Korboukh; Jamie J Arnold; Eric D Smidansky; Laura L Marcotte; David W Gohara; Xiaorong Yang; María Antonieta Sánchez-Farrán; David Filman; Janna K Maranas; David D Boehr; James M Hogle; Coray M Colina; Craig E Cameron
Journal:  J Biol Chem       Date:  2014-11-06       Impact factor: 5.157

5.  Structure-function relationships underlying the replication fidelity of viral RNA-dependent RNA polymerases.

Authors:  Grace Campagnola; Seth McDonald; Stéphanie Beaucourt; Marco Vignuzzi; Olve B Peersen
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

Review 6.  The uncoupling of catalysis and translocation in the viral RNA-dependent RNA polymerase.

Authors:  Bo Shu; Peng Gong
Journal:  RNA Biol       Date:  2017-03-01       Impact factor: 4.652

7.  Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.

Authors:  Devendra K Rai; Fayna Diaz-San Segundo; Grace Campagnola; Anna Keith; Elizabeth A Schafer; Anna Kloc; Teresa de Los Santos; Olve Peersen; Elizabeth Rieder
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

8.  Dengue Virus Evolution under a Host-Targeted Antiviral.

Authors:  Emily Plummer; Michael D Buck; Marisa Sanchez; Jason A Greenbaum; Julia Turner; Rajvir Grewal; Brennan Klose; Aruna Sampath; Kelly L Warfield; Bjoern Peters; Urban Ramstedt; Sujan Shresta
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

Review 9.  The role of mutational robustness in RNA virus evolution.

Authors:  Adam S Lauring; Judith Frydman; Raul Andino
Journal:  Nat Rev Microbiol       Date:  2013-03-25       Impact factor: 60.633

Review 10.  Population Diversity and Collective Interactions during Influenza Virus Infection.

Authors:  Christopher B Brooke
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.